USPTF guidelines – please help!
Please submit your comments to the USPTF. We need 30,000 by November https://web.archive.org/web/20111210163948/http://www.uspreventiveservicestaskforce.org:80/uspstf%5Fform3/
Please submit your comments to the USPTF. We need 30,000 by November https://web.archive.org/web/20111210163948/http://www.uspreventiveservicestaskforce.org:80/uspstf%5Fform3/
This particular topic may be the most important. A few have tried to put the discussion about its importance on the table (ref. this document published by the AUA back in 2005), but perhaps old habits die hard? General cancer conferences are mandated by the Commission on Cancer (CoC). You can’t be a community cancer [...]
Over treatment is the big issues thrown out there in any discussion about why men shouldn’t screen. So a couple of years ago the concept of Active Surveillance began to gain broader conceptual adoption. It’s generally considered to be a good smart option for maybe as many as half of men who are diagnosed, provided [...]
Without getting into any details about side-effects, from what I understand, a lot of prostate cancer patients experience them, and many exit treatment feeling unprepared for the physical and psychological burden associated with them. What’s worse, some “don’t want to talk about them” even to the extent of living with side-effects for years without being [...]
Over the next few days, in honor of breast cancer awareness month, I’ll attempt some interesting and non-funding related “analogies” where parallel programs to some surprisingly cost effective and simple, yet currently non-existent, cause components might be developed for prostate cancer. These ideas might improve patient quality of life, screening effectiveness, and advocacy in general.